2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
CNS
3
Conditions
Glioblastoma
3
Brain Edema
1
Interventions
Cyclophosphamide
2064
Radiotherapy
1984
Cisplatin
1851
Carboplatin
1557
Gemcitabine
1452
Paclitaxel
1320
Bevacizumab
1316
pembrolizumab
1235
Docetaxel
1225
Oxaliplatin
1181
Capecitabine
1173
Fluorouracil
1081
Dexamethasone
979
Magnetic Resonance Spectroscopy
967
Nivolumab
936
Rituximab
928
Drug Therapy
911
Surveys and Questionnaires
898
Doxorubicin
845
Etoposide
843
Radiosurgery
814
Blood Specimen Collection
814
Irinotecan
783
Cytarabine
743
fludarabine
723
Leucovorin
682
Surgical Procedures, Operative
638
Lenalidomide
618
Biopsy
592
fludarabine phosphate
568
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
antisecretory factor
×
Clear all
NCT07364786
2026-01-23
AFGBMBiop
Skane University Hospital
Phase 2
Recruiting
10 enrolled
NCT05669820
2026-01-09
AFGB2
Skane University Hospital
Phase 2/3
Recruiting
300 enrolled
NCT04116138
2021-04-28
AFGBM1
Skane University Hospital
Phase 1/2
Completed
8 enrolled